サマリー

アジア太平洋地域のラジオイムノアッセイ市場は、2023年から2030年の予測期間に3.5%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、予測期間は2023年から2030年です。
市場セグメンテーションを行います：
アジア太平洋ラジオイムノアッセイ市場、製品タイプ別（ラジオイムノアッセイ試薬・キット、ラジオイムノアッセイアナライザー）、用途別（科学研究、臨床診断）、エンドユーザー（病院、臨床診断研究所、学術・研究機関、製薬・バイオ医薬品産業、受託研究機関、その他）、流通チャネル（直接入札、オンライン販売、第三者流通、その他）、国（中国、日本、インド、韓国、オーストラリア、インドネシア、フィリピン、タイ、マレーシア、シンガポール、アジア太平洋地域以外） 産業動向と2030年までの予測

アジア太平洋地域のラジオイムノアッセイ市場の成長に寄与する主な要因には、以下のようなものがあります：
- 高スループットと自動化された手順による、エラーのない正確な結果に対する需要の増加 技術的進歩の上昇
- 市場関係者の戦略的な取り組み
- 医学における研究開発の意義が高まる

市場のプレーヤー：

アジア太平洋地域のラジオイムノアッセイ市場の主要な市場関係者は以下の通りです：

- パーキンエルマー株式会社
- エムピーバイオメディカルズ
- テカントレーディングAG
- メルクKGaA
- 株式会社イムノバイオロジーラボラトリーズ
- EUROIMMUN Medizinische Labordiagnostika AG（ユーロイムン メディジニッシェ ラボルダグノスティカ アグ
- ベックマン・コールター社
- ベルソルトテクノロジーズGmbH & Co.KG
- ハイデックスOy.
- アブカム・ピーエルシー

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 65
1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF ASIA PACIFIC RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67
2 MARKET SEGMENTATION 71
2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83
3 EXECUTIVE SUMMARY 84
4 PREMIUM INSIGHTS 87
4.1 PESTEL ANALYSIS 88
4.2 PORTYER’S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90
5 INDUSTRY INSIGHTS: 91
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94
7 MARKET OVERVIEW 95
7.1 DRIVERS 97
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
7.4.1 LACK OF SKILLED PROFESSIONALS 103
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103
8 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104
8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
8.2.1 KITS 109
8.2.2 BUFFER 109
8.2.2.1 SOLUTION 109
8.2.2.2 POWDER 109
8.2.3 STANDARD CONCENTRATES 110
8.2.4 PRECIPITATING REAGENTS 110
8.2.5 RADIOISOTOPES 110
8.2.5.1 BETA EMITTERS 110
8.2.5.1.1 TRITIUM 110
8.2.5.1.2 CARBON-14 111
8.2.5.2 GAMMA EMITTERS 111
8.2.5.2.1 IODINE-125 111
8.2.5.2.2 CHROMIUM-51 111
8.2.5.2.3 COBALT-57 111
8.2.6 ANTIBODY/ANTISERUM 112
8.2.6.1 POLYCLONAL 112
8.2.6.2 MONOCLONAL 112
8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113
9 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION 114
9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
9.3.1 INFECTIOUS DISEASE TESTING 120
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
9.3.2 ALLERGY TESTING 121
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
9.3.3 ONCOLOGY TESTING 121
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.4 ENDOCRINE TESTING 122
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.5 TOXICOLOGY TESTING 123
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
9.3.6 AUTOIMMUNE DISEASE TESTING 123
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
9.3.7 OTHER DISEASE TESTING 124
10 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER 125
10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132
11 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133
11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140
12 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY REGION 141
12.1 ASIA-PACIFIC 142
12.1.1 CHINA 154
12.1.2 JAPAN 161
12.1.3 INDIA 168
12.1.4 SOUTH KOREA 176
12.1.5 AUSTRALIA 184
12.1.6 INDONESIA 192
12.1.7 PHILIPPINES 199
12.1.8 THAILAND 207
12.1.9 MALAYSIA 215
12.1.10 SINGAPORE 222
12.1.11 REST OF ASIA-PACIFIC 230
13 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 231
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 231
14 SWOT ANALYSIS 232
15 COMPANY PROFILE 233
15.1 PERKINELMER INC. 233
15.1.1 COMPANY SNAPSHOT 233
15.1.2 REVENUE ANALYSIS 233
15.1.3 COMPANY SHARE ANALYSIS 234
15.1.4 PRODUCT PORTFOLIO 234
15.1.4 RECENT DEVELOPMENT 235
15.2 MERCK KGAA 236
15.2.1 COMPANY SNAPSHOT 236
15.2.2 REVENUE ANALYSIS 236
15.2.3 COMPANY SHARE ANALYSIS 237
15.2.4 PRODUCT PORTFOLIO 237
15.2.5 RECENT DEVELOPMENTS 237
15.3 BECKMAN COULTER, INC. 239
15.3.1 COMPANY SNAPSHOT 239
15.3.2 COMPANY SHARE ANALYSIS 239
15.3.3 PRODUCT PORTFOLIO 239
15.3.4 RECENT DEVELOPMENT 240
15.4 ABCAM PLC 241
15.4.1 COMPANY SNAPSHOT 241
15.4.2 REVENUE ANALYSIS 241
15.4.3 COMPANY SHARE ANALYSIS 242
15.4.4 PRODUCT PORTFOLIO 242
15.4.5 RECENT DEVELOPMENT 242
15.5 TECAN TRADING AG 243
15.5.1 COMPANY SNAPSHOT 243
15.5.2 REVENUE ANALYSIS 243
15.5.3 COMPANY SHARE ANALYSIS 244
15.5.4 PRODUCT PORTFOLIO 244
15.5.5 RECENT DEVELOPMENT 245
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 246
15.6.1 COMPANY SNAPSHOT 246
15.6.2 PRODUCT PORTFOLIO 246
15.6.3 RECENT DEVELOPMENTS 246
15.7 DEMEDITEC DIAGNOSTICS GMBH 247
15.7.1 COMPANY SNAPSHOT 247
15.7.2 PRODUCT PORTFOLIO 247
15.7.3 RECENT DEVELOPMENTS 248
15.8 DIASOURCE 249
15.8.1 COMPANY SNAPSHOT 249
15.8.2 PRODUCT PORTFOLIO 249
15.8.3 RECENT DEVELOPMENT 249
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 250
15.9.1 COMPANY SNAPSHOT 250
15.9.2 PRODUCT PORTFOLIO 250
15.9.3 RECENT DEVELOPMENTS 250
15.10 HIDEX OY 252
15.10.1 COMPANY SNAPSHOT 252
15.10.2 PRODUCT PORTFOLIO 252
15.10.3 RECENT DEVELOPMENTS 252
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 253
15.11.1 COMPANY SNAPSHOT 253
15.11.2 PRODUCT PORTFOLIO 253
15.11.3 RECENT DEVELOPMENT 255
15.12 INSTITUTE OF ISOTOPES 256
15.12.1 COMPANY SNAPSHOT 256
15.12.2 PRODUCT PORTFOLIO 256
15.12.3 RECENT DEVELOPMENTS 257
15.13 KAMIYA BIOMEDICAL COMPANY 258
15.13.1 COMPANY SNAPSHOT 258
15.13.2 PRODUCT PORTFOLIO 258
15.13.3 RECENT DEVELOPMENTS 258
15.14 MP BIOMEDICALS 259
15.14.1 COMPANY SNAPSHOT 259
15.14.2 PRODUCT PORTFOLIO 259
15.14.3 RECENT DEVELOPMENTS 260
15.15 MYBIOSOURCE.COM. 261
15.15.1 COMPANY SNAPSHOT 261
15.15.2 PRODUCT PORTFOLIO 261
15.15.3 RECENT DEVELOPMENT 261
16 QUESTIONNAIRE 262
17 RELATED REPORTS 265

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 58
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 63
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 64
TABLE 4 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 5 ASIA PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 6 ASIA PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 7 ASIA PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 8 ASIA PACIFIC RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 9 ASIA PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 10 ASIA PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 11 ASIA PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 77
TABLE 12 ASIA PACIFIC RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 13 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 82
TABLE 14 ASIA PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 15 ASIA PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 83
TABLE 16 ASIA PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 17 ASIA PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 18 ASIA PACIFIC INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 85
TABLE 19 ASIA PACIFIC ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 20 ASIA PACIFIC ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 ASIA PACIFIC ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
TABLE 22 ASIA PACIFIC TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 88
TABLE 23 ASIA PACIFIC AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 88
TABLE 24 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 93
TABLE 25 ASIA PACIFIC HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 26 ASIA PACIFIC CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 27 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 ASIA PACIFIC PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 29 ASIA PACIFIC CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 30 ASIA PACIFIC OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 101
TABLE 32 ASIA PACIFIC DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 ASIA PACIFIC ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 34 ASIA PACIFIC THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 35 ASIA PACIFIC OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 36 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 111
TABLE 37 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 38 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 39 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 40 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 41 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 42 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 43 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 44 ASIA-PACIFIC RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 45 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 46 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 47 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 48 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 49 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 50 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 51 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 114
TABLE 52 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 115
TABLE 53 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 115
TABLE 54 ASIA-PACIFIC RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 55 ASIA-PACIFIC RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 56 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 57 ASIA-PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 58 ASIA-PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 59 ASIA-PACIFIC INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 ASIA-PACIFIC ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 61 ASIA-PACIFIC ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 62 ASIA-PACIFIC ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 63 ASIA-PACIFIC TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 64 ASIA-PACIFIC AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 65 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 66 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 67 CHINA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 69 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 70 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 119
TABLE 71 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 72 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 73 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 74 CHINA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 75 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 76 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 77 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 78 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 79 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 80 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 81 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 122
TABLE 82 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 122
TABLE 83 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 122
TABLE 84 CHINA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 85 CHINA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 86 CHINA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 122
TABLE 87 CHINA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 88 CHINA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 89 CHINA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 90 CHINA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 91 CHINA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 92 CHINA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 93 CHINA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 124
TABLE 94 CHINA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 95 CHINA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 96 CHINA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 97 JAPAN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 98 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 99 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 126
TABLE 100 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 126
TABLE 101 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 102 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 127
TABLE 103 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 127
TABLE 104 JAPAN RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 105 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 106 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 107 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 108 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 109 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 110 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 111 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 129
TABLE 112 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 129
TABLE 113 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 129
TABLE 114 JAPAN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 115 JAPAN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 116 JAPAN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 117 JAPAN SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 118 JAPAN CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 119 JAPAN INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 120 JAPAN ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 121 JAPAN ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 122 JAPAN ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 123 JAPAN TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 131
TABLE 124 JAPAN AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 125 JAPAN RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 132
TABLE 126 JAPAN RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
TABLE 127 INDIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 128 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 129 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 133
TABLE 130 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 133
TABLE 131 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 132 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 134
TABLE 133 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 134
TABLE 134 INDIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 135 INDIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134